Grant Medical Center
Columbus, Ohio, United States
Hospital in Columbus, Ohio
111 S Grant Ave, Columbus, OH 43215
434 Beds
About Grant Medical Center
Grant Medical Center was established in 1900 in downtown Columbus, Ohio as the second member hospital of OhioHealth, a not-for-profit, faith-based healthcare system. Grant Medical Center is a Level I Trauma Center.
There are 434 beds in Grant Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
128
SWOG Cancer Research Network
38
Alliance for Clinical Trials in Oncology
25
ECOG-ACRIN Cancer Research Group
12
GOG Foundation
7
Gynecologic Oncology Group
6
NRG Oncology
5
Boston Scientific Corporation
4
OhioHealth
4
Wake Forest University Health Sciences
4
Major Extremity Trauma Research Consortium
2
Clinical Trials at Grant Medical Center
During the past decade, Grant Medical Center conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 113 clinical trials were completed, i.e. on
average, 101.8% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 51 clinical trials were completed. i.e. 196.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
2005-06-01
2012-08-01
Completed
823
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
2006-07-25
2019-02-11
Completed
57
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Grant Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 128 trials, followed by "SWOG Cancer Research Network" with 38 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "GOG Foundation"
with 12 trials sponsored. Other sponsors include 29 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Grant Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at Grant Medical Center
According to Clinical.Site data, the most researched conditions in "Grant Medical Center" are
"Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Breast Cancer AJCC v6 and v7" (10 trials) and "Stage IV Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "Grant Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Grant Medical Center
Most popular intervention types in "Grant Medical Center" are "Drug" (189 trials), "Other" (154 trials), "Biological" (104 trials), "Procedure" (53 trials) and "Radiation" (23 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (36 trials), "Paclitaxel" (34 trials) and "Carboplatin" (32 trials). Other intervention names were less common.
Clinical Trials Genders at Grant Medical Center
The vast majority of trials in "Grant Medical Center" are
189 trials for "All" genders, 52 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Grant Medical Center
Currently, there are NaN active trials in "Grant Medical Center".
undefined are not yet recruiting,
45 are recruiting,
111 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 67 completed trials in Grant Medical Center,
2 suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Grant Medical Center, 9 "Phase 1"
clinical trials were conducted, 109 "Phase 2" clinical
trials and 120 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 11 trials that are defined as “Not Applicable".